Living with ulcerative colitis (UC) can mean managing unpredictable symptoms that affect daily routines, work, and overall quality of life. For many people, the experience may also be shaped by gaps in care and frustration when previous treatments have not worked as expected.
UC care often involves different steps of treatment over time. Two important concepts you may hear about are induction and maintenance. These approaches are used in both standard care and clinical research to better understand how symptoms are managed and how improvements may be sustained. Clinical research studies, including the EMERALD-3 UC Study, are designed to study how UC impacts those living with the condition during treatment and beyond while closely monitoring safety. Click here to learn more.
Table of Contents
What Is Induction Treatment?
Induction refers to treatment aimed at reducing inflammation and improving symptoms. The goal is to help the body respond to therapy and move toward better disease control.
In both clinical care and research settings, induction allows healthcare providers and researchers to:
- Evaluate how a treatment works early on
- Monitor symptom changes
- Closely track safety and tolerability
In the EMERALD-3 UC Study, induction lasts approximately 10 weeks. During this time, researchers monitor response to the investigational study treatment and placebo to better understand early treatment effects and safety.
Why Induction Matters
UC is a chronic condition, and symptoms can change over time. Induction helps address key questions during the initial phase of therapy, such as:
- Are symptoms improving or changing?
- How is the body responding to treatment?
- Is the treatment being tolerated safely?
This plays an important role in determining whether a treatment shows potential to continue being studied and helps researchers gather early data that may inform future research.
What Happens After Symptoms Improve
For some individuals, symptom improvement during induction may lead to another step of care known as maintenance.
In the EMERALD-3 UC Study:
- Individuals who respond during induction may move into a period of longer-term maintenance, where researchers continue to monitor health and track whether improvements last over time
- Individuals who do not respond may still continue in the study with open-label treatment and ongoing monitoring
This structure reflects the reality of living with UC, because managing the condition continues even when symptoms begin to improve.
What Is Maintenance Care?
Maintenance focuses on longer-term disease management. It looks at whether symptom improvements can be sustained safely and how people feel and function over time.
During maintenance, researchers may evaluate:
- Ongoing symptom patterns
- Day-to-day functioning and quality of life
- Continued safety through regular monitoring
Maintenance research helps answer the common questions regarding sustaining symptom improvement and what long-term care looks like.
How Researchers Assess Response Over Time
Researchers use a combination of clinical assessments and patient-reported information, which may include:
- Changes in bowel urgency or frequency
- Levels of rectal bleeding
- Inflammation markers
- Overall symptom patterns over time and changes seen on imaging
Responses can vary from person to person. For minority populations who have historically been underrepresented in UC research, participation during both induction and maintenance helps ensure that long-term data reflect a broader range of lived experiences.
Safety Throughout Induction and Maintenance
Safety is a priority throughout the duration of clinical research. Individuals who join a study may receive:
- Regular health check-ins
- Lab work and ongoing monitoring
- Opportunities to share side effects, concerns, or questions
Any changes are carefully reviewed by the study team. Participation in clinical research is always voluntary, and individuals may choose to leave the study at any time.
Why Participation and Engagement Matter
Long-term engagement in clinical research helps researchers better understand how investigational treatments are studied over time and how they may affect quality of life. This research contributes to more inclusive data and supports future advances in UC care.
For those living with UC, participation offers an opportunity to help shape future treatment options by ensuring that research reflects the needs, experiences, and perspectives of communities that have often been underrepresented.
Learning More
Understanding induction and maintenance care can help you make more informed decisions about UC management and whether clinical research may be an option for you.
Learning more about studies like EMERALD-3 is one step toward care that better reflects the communities most impacted by UC. Click here to learn more and see whether joining a clinical research study may be an option for you.
